A new CSP position was established today on Abbott Laboratories (ABT). All prices include IB commissions.
This is the second position on ABT.
| Criteria | Value |
|---|---|
| Dividend Champions Status | Champion |
| Years of Consecutive Dividend Increases | 39 |
| Years of Positive Free Cash Flow (last 10 years) | 10 |
| Fair Value Estimate | $68.00 |
| Target Buy Price | $54.40 |
| Target Margin of Safety | 20.00% |
| Actual Buy Price | $52.50 |
| Actual Margin of Safety | 22.79% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|---|---|---|---|---|---|
| 1/25/2012 | ABT | CSP Margin Used | CSP 100 ABT @ 52.50 | ($5,250.00) | ||
| 1/25/2012 | ABT | Initial Put Option | STO 1 May12 52.50 Put @ 1.00 | $100.12 |
Position Summary
| Cost Basis | ($5,250.00) |
| Income Generated | $100.12 |
| Percent Income Generated | 1.91% |
| Annualized Income Generated | 6.11% |
| Net Profit If Assigned | $100.12 |
| Percent Return If Assigned | 1.91% |
| Annualized Return If Assigned | 6.11% |
| Days Held to Expiration | 114 days |
